CLINICAL_TRIALS
trial_result
· 2018-07-23
Clinical Trial Update: Fulvestrant in Metastatic Breast Cancer [Phase 4]
Summary
An update on a Phase 4 trial evaluating fulvestrant in metastatic breast cancer. The current trial status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assiut University | Conditions: Metastatic Breast Cancer | Phase 4 | Status: UNKNOWN